A review of premature birth and subclinical infection

American Journal of Obstetrics and Gynecology

Volumn 166, Issue 5, 1992, Pages 1515-1528

  Gibbs, R S ^a   Romero, R ^b   Hillier, S L ^c   Eschenbach, D A ^c   Sweet, R L ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antibiotics; biochemical mechanisms; chorioamnionitis; Premature birth; subclinical infection

Indexed keywords

AMOXICILLIN; AMPICILLIN; CLAVULANIC ACID; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; MEZLOCILLIN;

AMNIONITIS; INTRAUTERINE INFECTION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW;

ANTIBIOTICS; BACTERIAL INFECTIONS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMAN; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; LABOR, PREMATURE; PREGNANCY; TRICHOMONAS INFECTIONS;

EID: 0026546156     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(92)91628-N     Document Type: Article

References (161)

1. Relevance of correlates of infant deaths for significant morbidity at 1 year of age
2. Causes of perinatal mortality in the US Collaborative Perinatal Project
3. Factors that predispose to premature rupture of the fetal membranes
4. Causes and consequences of premature rupture of fetal membranes
5. Premature rupture of the membranes
6. Risk factors for prematurity and premature rupture of membranes a prospective study of the vaginal flora in pregnancy
7. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity
8. The incidence of prenatal syphilis at the Boston City Hospital
9. Congenital syphilis: the University of Miami/Jackson Memorial Medical Center experience, 1986–1988
10. Symptomatic gonorrhea during pregnancy
11. Neonatal gonococcal infection orogastric contamination with Neisseria gonorrhoeae
12. Symptomatic gonorrhea and pregnancy
13. Gonorrhea in pregnancy
14. Maternal gonococcal infection as a preventable risk factor for low birth weight
15. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women
16. Premature delivery and group B streptococcal bacteriuria
17. Antibiotic elimination of group-B streptococci in urine in prevention of preterm labour
18. The influence of advancing gestation on group B streptococcal colonization in pregnant women
19. Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers
20. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy
21. Group B streptococcal colonization and the outcome of pregnancy
22. Spontaneous early preterm labour associated with abnormal genital bacterial colonization
23. Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth
24. Perinatal complications in group B streptococcal carriers: a longitudinal study of prenatal patients
25. The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome
26. Isolation of Mycoplasma hominis, T-strains, and cytomegalovirus from the cervix of pregnant women
27. Birth weight and genital mycoplasmas in pregnancy
28. Genital mycoplasmas as a cause of excess premature delivery
29. Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy: Epidemiology and outcomes
30. The effect of genital mycoplasmas on human fetal growth
31. Genital mycoplasmas and birth weight in offspring of primigravid women
32. The role of mycoplasmas in reproduction
33. Chlamydia trachomatis infection and pregnancy outcome
34. Low birth weight, prematurity and postpartum endometritis: association with prenatal cervical Mycoplasma hominis and Chlamydia trachomatis infection
35. Association of Chlamydia trachomatis and Mycoplasma hominis with intrauterine growth retardation and preterm delivery
36. Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections
37. A prospective study of chlamydia and mycoplasmal infections during pregnancy
38. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome
39. Antepartum cultures for Ureaplasma urealyticum are not useful in predicting pregnancy outcome
40. A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery
41. Association of Chlamydia trachomatis and Mycoplasma hominis with intrauterine growth retardation and preterm delivery
42. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome
43. Trichomonas in pregnancy
44. Trichomonas infection in pregnancy—does it affect perinatal outcome?
45. Vaginal infections and preterm labour
46. Vaginal Bacteroides are associated with an increased rate of preterm delivery among women in preterm labor
47. Anaerobic bacteria in non-specific vaginitis
48. Bacterial vaginosis during pregnancy: an association with prematurity and postpartum complications
49. Bacteriuria and pyelonephritis of pregnancy
50. Pyelonephritis and bacteriuria: a major problem in preventative medicine
51. Layton R. Infection of the urinary tract in pregnancy: an investigation of a new routine in antenatal care. Br J Obstet Gynecol 71:927.
52. Bacteriuria in pregnancy
53. Bacteriuria, prematurity, and the hypertensive disorders of pregnancy
54. The incidence of urinary infection in 5000 pregnant women
55. Effect of bacteriuria on the fetus
56. The significance of bacteriuria in pregnancy
57. Demographic and prognostic characteristics of bacteriuria in pregnancy
58. Influence of maternal renal infection on the fetus and infant
59. The management and complications of asymptomatic bacteriuria in pregnancy
60. Subclinical renal infection and prematurity
61. The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy
62. The effects of bacteriuria in pregnancy on maternal and fetal health
63. Asymptomatic bacteriuria in pregnancy and its association with prematurity
64. Asymptomatic bacteriuria in pregnancy
65. Bacteriuria of pregnancy
66. Bacteriuria in pregnancy
67. Infection and preterm labor
68. Histologic chorioamnionitis and preterm delivery in different patient populations
69. Inflammatory lesions of the human placenta. I. Clinical significance of acute chorioamnionitis
70. The association of chorioamnionitis with preterm delivery
71. Placental microbiology and histology and the pathogenesis of chorioamnionitis
72. Chorioamnionitis and the isolation of microorganisms from the placenta
73. Chorioamnionitis: its association with pregnancy outcome and microbial infection
74. Histologic chorioamnionitis, microbial infection and prematurity
75. A microbiologic and clinical study of placental inflammation at term
76. Acute Haemophilus influenzae chorioamnionitis associated with intact amniotic membranes
77. Gonococcal chorioamnionitis associated with sepsis: a case report
78. Bacteria and inflammatory cells reduce chorioamniotic membrane integrity and tensile strength
79. Prostaglandin E production by the fetal membranes in unexplained preterm labour and preterm labour associated with chorioamnionitis
80. Production of prostaglandin E2 by human amnion in vitro in response to addition of media conditioned by microorganisms associated with chorioamnionitis and preterm labor
81. Evaluation of amniotic fluid in preterm labor with intact membranes
82. Intra-amniotic bacterial colonization in premature labor
83. Subclinical intra-amniotic infection in asymptomatic patients with refractory preterm labor
84. Amniocentesis and the management of premature labor
85. Bacterial colonization of amniotic fluid from intact fetal membranes
86. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes
87. Amniotic fluid infection as determined by transabdominal amniocentesis in patients with intact membranes in premature labor
88. Preterm labor associated with subclinical amniotic fluid infection and with subclinical bacterial vaginosis
89. The incidence of positive amniotic fluid cultures in patients in preterm labor with intact membranes
90. Low incidence of positive amniotic fluid cultures in preterm labor at 27-32 weeks in the absence of clinical evidence of chorioamnionitis
91. Correlation of maternal serum C-reactive protein with outcome of tocolysis
92. The association of subclinical infection with preterm labor: the role of C-reactive protein
93. Maternal C-reactive protein and preterm labor
94. Does extra-am-niotic infection cause preterm labor?
95. Evaluation of gas-liquid chromatography for the rapid diagnosis of amniotic fluid infection: a preliminary report
96. The mechanism(s) of human parturition
97. Endocrinology of preterm birth
98. Decidual activation: the role of prostaglandin in labor
99. Role of prostaglandin, prostacyclin, and thromboxanes in the physiologic control of the uterus and in parturition
100. Control of myometrial function in preterm versus term labor
101. Plasma concentrations of prostaglandin during late human pregnancy: influence of normal and preterm labor
102. A comparison of plasma prostaglandin levels in term and preterm labour
103. Concentrations of prostaglandin in amniotic fluid in premature labor
104. Prostaglandin F metabolite concentration as a prognostic factor in preterm labor
105. F prostaglandin levels in amniotic fluid in premature labor
106. 2 in preterm labor
107. Amniotic fluid concentrations of prostaglandin F2 alpha, 13,14-dihydro-15-keto-11,16-cyclo prostaglandin E2 (PGEM-II) in preterm labor
108. Prostaglandin concentrations in amniotic fluid of women with intraamniotic infection and preterm labor
109. Prostaglandin E production by the fetal membranes in unexplained preterm labor and preterm labor associated with chorioamnionitis
110. 2α in amniotic fluid before and during term and preterm labor
111. Increased concentrations of arachidonic acid lipoxygenase metabolites in amniotic fluid during parturition
112. 4 concentration in term human parturition
113. The effects of lipoxygenase metabolites of arachidonic acid on human myo-metrial contractility
114. Amniotic fluid 5-hydroxy-eicosatetraenoic acid in term labor
115. Involvement of lipoxygenase products in myometrial contractions
116. Amniotic fluid 5-hydroxyeicosatetraenoic acid in preterm labor
117. Amniotic fluid ar-achidonate lipoxygenase metabolites in women with preterm labor
118. Arachidonate lipoxygenase metabolites in amniotic fluid of women with intra-amniotic infection and preterm labor
119. Prostaglandin chorioamnionitis and preterm labour
120. 2 formation in isolated sensitized guinea pig lungs
121. 4 induce prostaglandin and thromboxane release from rat peritoneal macrophages
122. 4 and phosphatidic acid are calcium ionophores: studies employing arsenazo III in liposomes
123. Premature labor: bacterial source of phospholipase
124. Phospholipase C activity in microorganisms associated with reproductive tract infection
125. Effects of bacterial production prostaglandin E production by amnion cells
126. Preterm labor: stimulation of arachidonic acid metabolism in human amnion by bacterial products
127. 2 by human amnion in vitro in response to addition of media conditioned by microorganisms associated with chorioamnionitis and preterm labor
128. 2 production by human amnion
129. Bacterial endotoxin and tumor necrosis factor stimulate prostaglandin production by human decidua
130. Infection and labor: the detection of endotoxin in amniotic fluid
131. Assay of bacterial endotoxin (lipopolysaccharide) in human amniotic fluids: potential usefulness in diagnosis and management of preterm labor
132. Labor and infection. II. Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor
133. Mitchell MD, Romero R, Avila C, et al. Prostaglandin production by amnion and decidual cells in response to bacterial products. Prostaglandins Leukot Essent Fatty Acids [In press].
134. Interleukin-1 stimulates prostaglandin biosynthesis by human amnion
135. Prostaglandin biosynthesis by human decidual cells: effects of inflammatory mediators
136. Human decidua: a source of interleukin-1
137. Infection and labor. III. Interleukin-1: a signal for the onset of parturition
138. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor
139. Cachectin/tumor necrosis factor-formation in human decidua
140. Romero R, Manogue K, Oyarzun E, et al. Human decidua: a source of tumor necrosis factor. Eur J Obstet Gynecol Reprod Biol [In press].
141. Amniotic fluid interleukin-6 in preterm labor: association with infection
142. Santhanam U, Avila C, Romero R, et al. Cytokines in normal and abnormal parturition: elevated amniotic fluid IL-6 levels in women with premature rupture of membranes associated with intrauterine infection. Cytokines [In press].
143. Effect on birth weight of erythromycin treatment of pregnant women
144. Cervicovaginal microflora and pregnancy outcomes: results of a double-blind, placebo-controlled trial of erythromycin treatment
145. Improved pregnancy outcome following successful treatment of chlamydial infection
146. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome
147. Adjunctive erythromycin treatment for idiopathic preterm labor: results of a randomized, double-blind, placebo-controlled trial
148. A randomized, blinded, placebo-controlled trial of antibiotics in idiopathic preterm labor
149. A randomized study of antibiotic therapy in idiopathic preterm labor
150. Erythromycin therapy for subclinical intrauterine infections in threatened preterm delivery—a preliminary report
151. Ampicillin prophylaxis in preterm premature rupture of membranes: a prospective randomized study
152. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study
153. Antibiotic therapy in preterm premature rupture of membranes: a randomized, prospective, double-blind trial
154. Expectant management of preterm ruptured membranes: effect of antimicrobial therapy on interval to delivery [Abstract]
155. Use of parenteral antibiotic therapy to eradicate bacterial colonization of amniotic fluid in premature rupture of membranes
156. Premature rupture of the membranes managed with a new cervical catheter
157. Transcervical amnionfusion of antibiotics: a basic study for managing premature rupture of membranes